![PDF) Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review | JOSEFINA DURAN and Michael Lavalley - Academia.edu PDF) Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review | JOSEFINA DURAN and Michael Lavalley - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46745835/mini_magick20190208-21276-1b8jjeh.png?1549692816)
PDF) Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review | JOSEFINA DURAN and Michael Lavalley - Academia.edu
![Vaccines | Free Full-Text | Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab Vaccines | Free Full-Text | Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab](https://www.mdpi.com/vaccines/vaccines-10-00901/article_deploy/html/images/vaccines-10-00901-g001-550.jpg)
Vaccines | Free Full-Text | Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
![Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/43/5/869/F2.large.jpg)
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology
![New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab | The Journal of Rheumatology New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/40/7/1230/F1.large.jpg)
New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab | The Journal of Rheumatology
![Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/43/5/869/F1.large.jpg)
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology
![PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients](https://i1.rgstatic.net/publication/317067565_B_cell_repopulation_kinetics_after_rituximab_treatment_in_ANCA-associated_vasculitides_compared_to_rheumatoid_arthritis_and_connective_tissue_diseases_A_longitudinal_observational_study_on_120_patient/links/595f4c3b458515a35790f41b/largepreview.png)
PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients
![Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis - Bénard - 2021 - ACR Open Rheumatology - Wiley Online Library Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis - Bénard - 2021 - ACR Open Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2efced7d-ba3a-450e-9568-8c9040e75316/acr211274-fig-0001-m.jpg)
Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis - Bénard - 2021 - ACR Open Rheumatology - Wiley Online Library
![Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis | The Journal of Rheumatology Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/48/10/1512/F1.large.jpg)
Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis | The Journal of Rheumatology
![Proposed algorithm for pulmonary symptoms in rheumatoid arthritis. In... | Download Scientific Diagram Proposed algorithm for pulmonary symptoms in rheumatoid arthritis. In... | Download Scientific Diagram](https://www.researchgate.net/publication/336497896/figure/fig1/AS:817035009343488@1571807734632/Proposed-algorithm-for-pulmonary-symptoms-in-rheumatoid-arthritis-In-the-setting-of.png)
Proposed algorithm for pulmonary symptoms in rheumatoid arthritis. In... | Download Scientific Diagram
![Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis | Journal of Comparative Effectiveness Research Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/cms/10.2217/cer-2017-0106/asset/images/medium/figure2.gif)
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis | Journal of Comparative Effectiveness Research
![JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)](https://pub.mdpi-res.com/jcm/jcm-10-03806/article_deploy/html/images/jcm-10-03806-g005.png?1629974482)
JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
![JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review](https://www.mdpi.com/jcm/jcm-09-03070/article_deploy/html/images/jcm-09-03070-g001-550.jpg)
JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
![PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies](https://i1.rgstatic.net/publication/46218276_The_Belgian_MIRA_MabThera_In_Rheumatoid_Arthritis_registry_Clues_for_the_optimization_of_rituximab_treatment_strategies/links/02e7e528dc6ee9cf51000000/largepreview.png)
PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies
![Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry | RMD Open Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry | RMD Open](https://rmdopen.bmj.com/content/rmdopen/1/1/e000034/F1.large.jpg)